Mirum Pharmaceuticals, Inc. MIRM
93.18 USD -0.54 (-0.58%)
At closeNov 10, 2026, 4:00 AM EST
77.83 -15.35 -16.47%
Pre-market · Nov 10, 4:00 AM ET
91.53 Day range 95.10
63.23 52-week range 130.00
- YTD
- +17.96%
- 1 year
- +36.81%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 521.31M | 336.89M | 186.37M | 77.06M | 19.14M | |
| 421.07M | 255.25M | 139.34M | 64.69M | 17.23M | |
| -22.14M | -87.61M | -109.15M | -131.22M | -173.41M | |
| -23.36M | -87.94M | -163.41M | -135.66M | -83.99M | |
| -0.47 | -1.85 | -4.00 | -4.02 | -2.77 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 298.17M | 222.93M | 286.33M | 128.00M | 131.34M | |
| 842.81M | 670.75M | 646.62M | 352.91M | 294.65M | |
| 528.12M | 445.11M | 397.95M | 210.87M | 174.44M | |
| 317.31M | 316.05M | 308.14M | 142.54M | 132.54M | |
| 314.69M | 225.64M | 248.67M | 142.04M | 120.21M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 55.83M | 10.32M | -70.94M | -120.14M | -132.76M | |
| -23.95M | -90.13M | -107.20M | 7.70M | 48.55M | |
| 40.14M | 17.70M | 336.60M | 109.09M | 73.47M | |
| -954.00K | -993.00K | -109.00K | -278.00K | 107.98M | |
| 75.24M | -63.40M | 158.32M | -3.34M | -10.75M |